PEAK6’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-40,000
Closed -$463K – 4487
2023
Q1
$463K Buy
+40,000
New +$398K ﹤0.01% 2452

Other funds holding PACB

PEAK6's PACB Position: Q3 2026 in Review

PEAK6 sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 555,552 shares — an estimated $784K sold.

PEAK6 first reported a position in PACB in Q2 2025 and held it in 4 quarters. The position peaked at $1.24M in Q2 2025. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • PEAK6 reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
  • PEAK6 sold 555,552 Pacific Biosciences shares in Q3 2026, an estimated $784K.
  • PEAK6 first reported a position in Pacific Biosciences in Q2 2025 and held it in 4 quarters.
  • PEAK6's Pacific Biosciences position peaked at $1.24M in Q2 2025.
  • 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.